A new trading day began on Tuesday, with Tarsus Pharmaceuticals Inc (NASDAQ: TARS) stock price down -3.93% from the previous day of trading, before settling in for the closing price of $82.11. TARS’s price has ranged from $38.51 to $82.42 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -66.60% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 51.83%. With a float of $39.10 million, this company’s outstanding shares have now reached $42.45 million.
Tarsus Pharmaceuticals Inc (TARS) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Tarsus Pharmaceuticals Inc is 7.88%, while institutional ownership is 104.94%. The most recent insider transaction that took place on Sep 24 ’25, was worth 332,220. In this transaction President/CEO and Board Chair of this company sold 6,000 shares at a rate of $55.37, taking the stock ownership to the 812,106 shares. Before that another transaction happened on Sep 24 ’25, when Company’s Officer proposed sale 6,000 for $55.37, making the entire transaction worth $332,208.
Tarsus Pharmaceuticals Inc (TARS) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.6 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 51.83% per share during the next fiscal year.
Tarsus Pharmaceuticals Inc (NASDAQ: TARS) Trading Performance Indicators
Here are Tarsus Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.25. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.01, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach 1.79 in one year’s time.
Technical Analysis of Tarsus Pharmaceuticals Inc (TARS)
Let’s dig in a bit further. During the last 5-days, its volume was 0.46 million. That was inferior than the volume of 0.64 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 79.05%.
During the past 100 days, Tarsus Pharmaceuticals Inc’s (TARS) raw stochastic average was set at 89.79%, which indicates a significant increase from 73.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.75 in the past 14 days, which was higher than the 2.48 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $67.87, while its 200-day Moving Average is $52.03. However, in the short run, Tarsus Pharmaceuticals Inc’s stock first resistance to watch stands at $82.23. Second resistance stands at $85.59. The third major resistance level sits at $87.70. If the price goes on to break the first support level at $76.76, it is likely to go to the next support level at $74.65. The third support level lies at $71.29 if the price breaches the second support level.
Tarsus Pharmaceuticals Inc (NASDAQ: TARS) Key Stats
With a market capitalization of 3.35 billion, the company has a total of 42,449K Shares Outstanding. Currently, annual sales are 182,950 K while annual income is -115,550 K. The company’s previous quarter sales were 118,700 K while its latest quarter income was -12,590 K.
